Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo study

The Journal of Allergy and Clinical Immunology

Volumn 77, Issue 3, 1986, Pages 488-496

  Hedlin, G ^a   Graff Lonnevig, V ^a   Heilborn, H ^a   Lilja, G ^a   Norrlind, K ^a   Pegelow, K O ^a   Sundin, B ^a   Lowenstein H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ASTHMA; CAT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DANDER; DESENSITIZATION; DOG; ETIOLOGY; HUMAN; HYPERSENSITIVITY; IMMUNOTHERAPY; LYMPHATIC SYSTEM; METHODOLOGY; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; RESPIRATORY SYSTEM; SKIN TEST; THERAPY;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANIMALS; CATS; CHILD; CLINICAL TRIALS; DOGS; DOUBLE-BLIND METHOD; EPITOPES; FEMALE; HAIR; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOTHERAPY; MALE; MIDDLE AGED; RADIOALLERGOSORBENT TEST; SKIN TESTS; TISSUE EXTRACTS;

EID: 0022623545     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(86)90184-3     Document Type: Article

References (44)

1. Allergy
2. Allergen-specific IgE and IgG antibodies in pollen-allergic children given immunotherapy for 2 to 6 years
3. Hyposensitization in childhood hay fever
4. Clinical studies of a purified timothy-pollen extract
5. Immunotherapy with grass pollen major allergens
6. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects
7. A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects
8. A controlled trial of immunotherapy in insect hypersensitivity
9. Experience in the hyposensitization treatment of animal dander-allergic patients with alum-precipitated pyridine extracts
10. Observation on animal-dander hyposensitization
11. Immunotherapy in catinduced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine
12. Immunotherapy with cat-and dog-dander extracts III Allergen-specific Ig responses from a 1-year double-blind placebo study
13. Immunotherapy with alginate-conjugated and alumprecipitated grass-pollen extracts in patients with allergic rhinoconjunctivitis
14. Nasal and skin sensitivity during immunotherapy with two major allergens 19 25 and partially purified extracts of timothy-grass pollen
15. Immunotherapy in hay fever with two major allergens 19 25 and partially purified extract of timothy-grass pollen A controlled double-blind study In vitro variables season 1
16. Clinical studies of a purified timothy-pollen extract: desensitization therapy with a purified timothy-pollen preparation compared to a crude timothy-pollen extract. II. Results of the tests in vitro and their relation to symptoms and tests in vivo
17. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy
18. In vitro investigations in asthmatic children undergoing hyposensitization with tyrosine-adsorbed Dermatophagoides pteronyssinus antigen
19. Clinical and immunological studies of venom immunotherapy
20. A review of immunotherapy
21. A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies
22. Studies in pollen allergy. III. The relationship between blocking antibody levels and symptomatic relief following hyposensitization with Allpyral in hay fever subjects
23. Antibody responses following immunotherapy with cat pelt extract
24. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy
25. Standardization of allergen extracts with appropriate methods
26. Diagnosis of allergy by an in vitro test for allergen antibodies
27. Purification of human IgE and rabbit anti-human IgE
28. The preparation and assessment of iodinated antigens
29. A threelayer immunoradiometric assay for determination of IgG subclass antibodies in human sera (“IgG subclass RAST”). Validation of the subclass specificity and establishment of equipotency
30. 125I-protein A from Staphylococcus aureus
31. Quantitation of antigen-specific immunoglobulin G in human serum II Comparison of radioimmunoprecipitation and solid-phase radioimmunoassay techniques for measurement of immunoglobulin G specific for a complex allergen mixture (yellow jacket venom)
32. The concentration of 21 serum proteins in normal children and adults
33. The effect of antigen injections on skin reactivity to antigens
34. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses
35. The influence of histamine on immune and inflammatory responses
36. Insect allergy: the state of the art
37. Serum IgE levels in healthy children quantified by a sandwich technique (PRIST)
38. Changes in skin-sensitizing antibody titer after injections of aqueous pollen extract
39. Studies of perennial ragweed immunotherapy
40. Predictive value of serum IgE levels during rush hyposensitization
41. Measurements of the absolute levels of IgE antibodies in patients with ragweed hay fever
42. Grass pollen hyposensitization versus placebo therapy. II. Immunotherapy-induced changes in serum IgE and IgG levels
43. An overview of immunotherapy: implications for the future
44. Clinical and immunologic aspects of allergenspecific immunotherapy in patients with seasonal allergic rhinitis and/or allergic asthma